サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542927

外部鼻孔拡張器の世界市場：2024年～2031年

Global External Nasal Dilator Market - 2024-2031

出版日
ページ情報
英文 182 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
外部鼻孔拡張器の世界市場：2024年～2031年
出版日: 2024年08月26日
発行: DataM Intelligence
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場概要

外部鼻孔拡張器の世界市場は、2023年に1億7,980万米ドルに達し、2031年には2億7,322万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは5.5%で成長する見込みです。

外部鼻孔拡張器（ENDs）は、中央の弾性ストリップを含む粘着性のバンドで、側鼻前庭の崩壊を防ぐことによって鼻の抵抗と吸気圧を軽減します。ENDは鼻背の皮膚に水平に装着します。

外部鼻孔拡張器はプラスチック製またはシリコン製の器具です。これは、バネのようなバンドが付いた2枚の帯状の接着剤で、鼻の両側を持ち上げて保持することにより鼻腔を拡張します。この作用により、鼻の気道抵抗が減少し、空気の流れが改善されます。

いびき、睡眠関連障害、鼻詰まりの有病率の増加や、この分野における非侵襲的な治療ソリューションの需要により、外付け鼻腔拡張器の市場は成長する可能性が高いです。

市場力学：

促進要因

いびきと睡眠障害に対する意識の高まり

外部鼻孔拡張器の世界市場の需要全体には、いくつかの要因が寄与しています。いびきや睡眠障害が健康に及ぼすリスクが広く知られるようになるにつれ、人々は睡眠中に非侵襲的に呼吸を改善する方法を探しています。外部鼻孔拡張器の進歩は、いびきを減少させ呼吸を促進するツールとして提唱され、市場の成長に寄与しています。

多くの人々が、鼻づまりや呼吸制限といった呼吸に関する問題に対処するために、非侵襲的な方法を探しています。外部鼻孔拡張器は、鼻呼吸困難を軽減するために鼻孔開口部の領域を移動させるための簡単で非外科的なオプションです。

さらに、新しい認識プログラムを導入する米国の大手企業は、この市場の成長を推進すると思われます。2023年2月、米国睡眠医学会は、閉塞性睡眠時無呼吸といびきに対する認識を高めるため、「More than a Snore」を開始しました。このキャンペーンは、睡眠時無呼吸症候群に対する国民の意識を高め、未診断の患者が自分自身とその治療を擁護するよう促すことを目的としています。

また、鼻孔拡張器は、スポーツ選手や運動する人がパフォーマンスを向上させるためによく使用します。これらのストリップは酸素摂取と換気を促進し、持久力と全般的なパフォーマンスを向上させると考えられています。

一般に、外部鼻孔拡張器は使い方が簡単で、特別な訓練や薬物療法を必要としないです。その魅力は、消費者が専門家の指導を必要とせずに使用できる利便性にあります。外部鼻孔拡張器の市販バージョンは、薬局、食料品店、オンライン小売店で広く入手可能です。簡単に入手できるため、鼻づまりや関連する問題の緩和を求める誰にとっても実用的な選択肢です。

抑制要因

デバイスの高価格、ダイレーターの再利用性の欠如、接着剤による皮膚刺激による不快感、認知度や採用率の不足、代替ソリューションとの競合、限られた製品オプション、特定のタイプのいびきに対する限定的な有効性などの要因が市場の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • いびきと睡眠障害に対する意識の高まり
      • スポーツ選手による鼻腔拡張の需要の増加
      • ヘルスケアにおける技術の進歩
    • 抑制要因
      • 装置の高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ
  • PESTEL分析
  • 特許分析
  • SWOT分析

第6章 COVID-19分析

第7章 製品タイプ別

  • 粘着式鼻腔拡張器
  • スプリング式鼻腔拡張器
  • 鼻孔ストリップ
  • 鼻クリップ

第9章 用途別

  • 鼻づまり
  • いびき
  • 競技時鼻腔拡張
  • 睡眠時無呼吸症候群
  • その他

第10章 年齢層別

  • 成人
  • 小児

第11章 販売チャネル別

  • 病院薬局
  • スポーツ・フィットネスセンター
  • 小売薬局
  • オンライン薬局
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • GlaxoSmithKline Plc
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • SleepRight
  • Health Right Products LLC
  • Walmart Inc
  • Airware Labs
  • Walgreen Co
  • SHREYAAS HEALTH CARE PVT LTD
  • Nasilator
  • Rhinomed Limited
  • McKeon Products, Inc（LIST NOT EXHAUSTIVE）

第15章 付録

目次
Product Code: MD1289

Market Overview

The Global External Nasal Dilators Market reached US$ 179.80 million in 2023 and is expected to reach US$ 273.22 million by 2031, growing at a CAGR of 5.5% during the forecast period 2024-2031.

External nasal dilators (ENDs) are adhesive bands containing a central elastic strip that reduce nasal resistance and inspiratory pressure by preventing the collapse of the lateral nasal vestibule. ENDs are applied horizontally to the skin of the nasal dorsum.

The external nasal dilator is a plastic or silicone device. It is 2 strips of adhesive with spring-like bands that expand the nasal passages by lifting and holding open the sides of the nose. This action decreases nasal airway resistance and allows improved airflow.

The market for external nasal dilators is likely to grow due to the increasing prevalence of snoring, sleep-related disorders & clogged noses among people as well as the demand for non-invasive treatment solutions in this area.

Market Dynamics: Drivers

Growing Awareness of Snoring and Sleep Disorders

Several factors contribute to the overall demand for the global external nasal dilator market. As the risks of snoring and sleep disorders to health become more widely known, people are looking for ways to breathe better while they sleep non-invasively. Advancements in external nasal dilators are advocated as tools to decrease snoring and facilitate respiration, contributing to market growth.

A lot of people look for non-invasive methods to deal with problems concerning breathing in ahead such as nasal congestion and restriction. External nasal dilators are simple and non-surgical options to move the area of the nostrils opening to reduce nasal breathing difficulties.

Moreover, major players in the U.S. introducing the new awareness program would propel this market growth. In February 2023, the American Academy of Sleep Medicine launched "More than a Snore" to raise awareness of obstructive sleep apnea and snoring. This campaign aims to raise national awareness of sleep apnea and encourage undiagnosed patients to advocate for themselves and their treatment.

In addition, nasal dilators are frequently used by athletes and those who exercise to improve their performance. These strips are thought to promote oxygen intake and ventilation, which could enhance endurance and general performance.

In general, external nasal dilators are simple to use and don't involve any special training or medication. Their appeal is attributed to their convenience since consumers can implement them without requiring expert guidance. The over-the-counter versions of external nasal dilators are widely accessible in pharmacies, grocery stores, and online retailers. They are a practical option for anyone looking for relief from nasal congestion and related problems because of their easy accessibility.

Restraints

Factors such as the high cost of the devices, lack of reusability of dilators, discomfort due to skin irritation from the adhesive, lack of awareness and adoption, competition from alternative solutions, limited product options, and their limited effectiveness for certain types of snoring these are expected to hamper the market.

Segment Analysis

The global external nasal dilator market is segmented based on product type, application, age group, sales channel, and region.

The nasal congestion segment accounted for approximately 67.4% of the global external nasal dilator market share

The nasal congestion segment is expected to hold the largest market share over the forecast period. Nasal congestion occurs when the nasal passages and the tissues around them as well as blood vessels swell due to excessive fluids. The blocked nose condition comes from this irritation that also gives one a sense of complexation or closure in the nostrils. For infants who cannot be fed due to the congestion or children whose sleep is disturbed by it, a child's stuffy nose could be very distressing.

The more extended their nasal cavity is, the folks with blocked noses get immensely alleviated by that alone. For instance, Bausch Health Companies Inc. revealed on May 2023 that RYALTRIS, a new medication combining mometasone furoate nasal spray with olopatadine hydrochloride can now be found throughout Canada.

Health Canada has authorized RYALTRIS for symptomatic medical management of adults, adolescents, and children six years of age and above having mild to severe spring allergic sinusitis (SAR) with related vision problems. The need for external nasal dilators is rising along with the frequency of nasal congestion, which is fueling the expansion of the external nasal dilator market globally throughout the forecast period.

Geographical Analysis

North America accounted for approximately 41.3% of the global external nasal dilator market share

North America region is expected to hold the largest market share over the forecast period due to the high frequency of long-term sinusitis, reputable suppliers, and rising knowledge of the advantages of external nasal dilatation over alternative techniques.

In the United States, obstructive sleep apnea will affect around 30 million persons by 2023. Roughly 80% of these cases go undetected, resulting in health care costs, decreased productivity at work, and workplace and auto accidents costing the United States more than $149 billion yearly.

Sleep problems can reduce productivity at work and have major health repercussions. According to CDC projections from August 2023, nearly one-third of adult Americans sleep fewer hours than recommended and sleep disorders represent a major public health emergency.

Additionally, the cost of healthcare has increased as a result of the growing prevalence of chronic diseases in North America. Due to the high prevalence of snoring, chronic sinusitis, and rhinosinusitis, North America is expected to have the highest revenue share in the global external nasal dilator market, which in turn drives the regional market during the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global external nasal dilator market. The pandemic affected the manufacture and delivery of a variety of commodities, including medical equipment like nasal strips and external nasal dilators, by upsetting global supply networks.

It's possible that lockdowns, travel restrictions, and labor scarcity contributed to supply and manufacturing delays. There may have been changes in consumer behavior during the epidemic, such as a greater emphasis on wellness and health items. It's possible that some people have become more interested in devices like external nasal dilators to breathe easier and sleep better.

Market Segmentation

By Product Type

  • Adhesive Nasal Dilator
  • Spring Nasal Dilator
  • Nasal Strips
  • Nasal Clips

By Application

  • Nasal Congestion
  • Snoring
  • Athletic Nasal Dilation
  • Sleep Apnea
  • Others

By Age Group

  • Adults
  • Pediatrics

By Sales Channel

  • End-User
  • Hospital Pharmacies
  • Sports and Fitness Centers
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the external nasal dilator market include GlaxoSmithKline Plc, SleepRight, Health Right Products LLC, Walmart Inc, Airware Labs, Walgreen Co, SHREYAAS HEALTH CARE PVT LTD, Nasilator, Rhinomed Limited, McKeon Products, Inc and among others.

Key Developments

  • In April 2024, Intake Breathing, a leading provider of innovative breathing solutions, announced the launch of its groundbreaking Intake Breathing nasal dilator. This two-part nasal dilator system is designed to dramatically open the nasal passages, allowing for improved breathing, deeper sleep, and enhanced overall well-being.
  • In February 2023, Johnson & Johnson MedTech introduced the RELIEVA TRACT nasal dilation system features a novel mechanism of action that empowers you to create space for your nasal procedures
  • In October 2021, Foundation Consumer Healthcare (FCH) announced a partnership with two-time NASCAR champion, Kyle Busch. Together, Busch and FCH are working to increase awareness of the potential benefits and uses of Breathe Right nasal strips.

Why Purchase the Report?

  • To visualize the global external nasal dilator market segmentation based on product type, application, age group, sales channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of global external nasal dilator market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global external nasal dilator market report would provide approximately 70 tables, 66 figures, and 182 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Age Group
  • 3.4. Snippet by Sales Channel
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Awareness of Snoring and Sleep Disorders
      • 4.1.1.2. Increased Demand from Athletes Nasal Dilation
      • 4.1.1.3. Technological Advancements in Healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. The High Cost of Devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • Adhesive Nasal Dilator*
  • 7.1. Introduction
  • 7.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Spring Nasal Dilator
  • 7.4. Nasal Strips
  • 7.5. Nasal Clips

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Nasal Congestion*
    • 9.2.1. Introduction
  • 9.3. Snoring
  • 9.4. Athletic Nasal Dilation
  • 9.5. Sleep Apnea
  • 9.6. Others

10. By Age Group

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.1.2. Market Attractiveness Index, By Age Group
  • 10.2. Adults*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Pediatrics

11. By Sales Channel

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 11.1.2. Market Attractiveness Index, By Sales Channel
  • 11.2. Hospitals Pharmacies*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Sports and Fitness Centers
  • 11.4. Retail Pharmacies
  • 11.5. Online Pharmacies
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.7.1. U.S.
      • 12.2.7.2. Canada
      • 12.2.7.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.7.1. Germany
      • 12.3.7.2. UK
      • 12.3.7.3. France
      • 12.3.7.4. Italy
      • 12.3.7.5. Spain
      • 12.3.7.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.7.1. Brazil
      • 12.4.7.2. Argentina
      • 12.4.7.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.7.1. China
      • 12.5.7.2. India
      • 12.5.7.3. Japan
      • 12.5.7.4. South Korea
      • 12.5.7.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. GlaxoSmithKline Plc *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio & Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. SleepRight
  • 14.3. Health Right Products LLC
  • 14.4. Walmart Inc
  • 14.5. Airware Labs
  • 14.6. Walgreen Co
  • 14.7. SHREYAAS HEALTH CARE PVT LTD
  • 14.8. Nasilator
  • 14.9. Rhinomed Limited
  • 14.10. McKeon Products, Inc (LIST NOT EXHAUSTIVE)

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us